Cargando…
Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence
Tobacco use is the top preventable cause of early mortality in schizophrenia. Over 60% of people with schizophrenia smoke, three times the general prevalence. The biological basis of this increased risk is not understood, and existing interventions do not target schizophrenia-specific pathology. We...
Autores principales: | Ward, Heather Burrell, Beermann, Adam, Nawaz, Uzma, Halko, Mark A., Janes, Amy C., Moran, Lauren V., Brady, Roscoe O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829345/ https://www.ncbi.nlm.nih.gov/pubmed/35153877 http://dx.doi.org/10.3389/fpsyt.2022.804055 |
Ejemplares similares
-
Noninvasive Brain Stimulation for Nicotine Dependence in Schizophrenia: A Mini Review
por: Ward, Heather Burrell, et al.
Publicado: (2022) -
Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
por: Sonnenschein, Susan F., et al.
Publicado: (2020) -
Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2021) -
Impact of Nicotine on Cognition in Patients With Schizophrenia: A Narrative Review
por: Spasova, Violeta, et al.
Publicado: (2022) -
A Preliminary Examination of Nicotine-Free Electronic Cigarette Use During Cessation From Combustible Cigarettes
por: Peechatka, Alyssa L., et al.
Publicado: (2019)